16beta-acetoxy-3beta-hydroxy-14Hbeta-17Hbeta-pregn-5-en-15-one-3-O-beta-D-glucopyranosyl-(1→4)-beta-D-oleandropyranosyl-(1→4)-beta-D-canaropyranosyl-(1→4)-beta-D-cymaropyranosyl-(1→4)-beta-D-cymaropyranoside - Compound Card

16beta-acetoxy-3beta-hydroxy-14Hbeta-17Hbeta-pregn-5-en-15-one-3-O-beta-D-glucopyranosyl-(1→4)-beta-D-oleandropyranosyl-(1→4)-beta-D-canaropyranosyl-(1→4)-beta-D-cymaropyranosyl-(1→4)-beta-D-cymaropyranoside

Select a section from the left sidebar

16beta-acetoxy-3beta-hydroxy-14Hbeta-17Hbeta-pregn-5-en-15-one-3-O-beta-D-glucopyranosyl-(1→4)-beta-D-oleandropyranosyl-(1→4)-beta-D-canaropyranosyl-(1→4)-beta-D-cymaropyranosyl-(1→4)-beta-D-cymaropyranoside

Structure
Zoomed Structure
  • Family: Plantae - Apocynaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Pregnane Glycoside
Canonical Smiles COC1CC(OC(C1OC1CC(O)C(C(O1)C)OC1CC(OC)C(C(O1)C)OC1OC(CO)C(C(C1O)O)O)C)OC1C(OC)CC(OC1C)O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@@H]3C(=O)[C@@H]([C@H]2CC)OC(=O)C)C)C1)C
InChI InChI=1S/C56H90O21/c1-12-33-53(71-29(6)58)46(61)44-32-14-13-30-19-31(15-17-55(30,7)34(32)16-18-56(33,44)8)72-41-21-36(64-9)51(26(3)68-41)76-43-22-37(65-10)50(27(4)69-43)75-40-20-35(59)49(25(2)67-40)74-42-23-38(66-11)52(28(5)70-42)77-54-48(63)47(62)45(60)39(24-57)73-54/h13,25-28,31-45,47-54,57,59-60,62-63H,12,14-24H2,1-11H3/t25?,26?,27?,28?,31-,32+,33+,34-,35?,36?,37?,38?,39?,40?,41?,42?,43?,44-,45?,47?,48?,49?,50?,51?,52?,53+,54?,55-,56+/m0/s1
InChIKey KLWQVIZETXOKLA-NHZPNSEQSA-N
Formula C56H90O21
HBA 21
HBD 5
MW 1099.31
Rotatable Bonds 16
TPSA 264.51
LogP 3.37
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 77
Formal Charge 0
Fraction CSP3 0.93
Exact Mass 1098.6
Number of Lipinski Rule Violations 2
# Species Family Kingdom NCBI Taxonomy ID
1 Solenostemma argel Apocynaceae Plantae 219273

Showing of synonyms

  • Ounaissia K, Pertuit D, et al. (2016). New pregnane and phenolic glycosides from Solenostemma argel. Fitoterapia, 2016, 114, 98-104. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O=C1CCC(C12)CCC3C2CC=C4C3CCC(C4)OC(OC5)CCC5OC(OC6)CCC6OC(OC7)CCC7OC(OC8)CCC8OC9CCCCO9

Level: 5

Mol. Weight: 1099.31 g/mol

Structure

SMILES: O=C1CCC(C12)CCC3C2CC=C4C3CCC(C4)OC(OC5)CCC5OC(OC6)CCC6OC(OC7)CCC7OC8CCCCO8

Level: 4

Mol. Weight: 1099.31 g/mol

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OC3CCC(OC3)OC4CCC(OC4)OC5CCCOC5

Level: 4

Mol. Weight: 1099.31 g/mol

Structure

SMILES: O=C1CCC(C12)CCC3C2CC=C4C3CCC(C4)OC(OC5)CCC5OC(OC6)CCC6OC7CCCCO7

Level: 3

Mol. Weight: 1099.31 g/mol

Structure

SMILES: C1OCCCC1OC(OC2)CCC2OC(OC3)CCC3OC4CCCCO4

Level: 3

Mol. Weight: 1099.31 g/mol

Structure

SMILES: O=C1CCC(C12)CCC3C2CC=C4C3CCC(C4)OC(OC5)CCC5OC6CCCCO6

Level: 2

Mol. Weight: 1099.31 g/mol

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OC3CCCOC3

Level: 2

Mol. Weight: 1099.31 g/mol

Structure

SMILES: O=C1CCC(C12)CCC3C2CC=C4C3CCC(C4)OC5CCCCO5

Level: 1

Mol. Weight: 1099.31 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1099.31 g/mol

Structure

SMILES: O=C1CCC(C12)CCC3C2CC=C4C3CCCC4

Level: 0

Mol. Weight: 1099.31 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1099.31 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.66
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
1110461.620
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
145125008.24

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.580
Plasma Protein Binding
66.4
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
4.100
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-3375280.180
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-2.780
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.050
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-263394884958.590
Rat (Acute)
4.630
Rat (Chronic Oral)
567.050
Fathead Minnow
332479741.390
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
29624618461.030
Hydration Free Energy
-2.920
Log(D) at pH=7.4
-16451.690
Log(P)
2.13
Log S
-4.85
Log(Vapor Pressure)
-975523580.06
Melting Point
145.72
pKa Acid
-7108135.7
pKa Basic
-57168.19
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7549

Download SDF